Indivior appoints Mark Crossley as CEO
(Sharecast News) - Indivior has promoted Mark Crossley to the role of chief executive officer, succeeding Shaun Thaxter.
Read more(Sharecast News) - Indivior has promoted Mark Crossley to the role of chief executive officer, succeeding Shaun Thaxter.
Read moreIndivior Reports Data From Transition Phase Of Opioid Recovery Study
Read more(Sharecast News) - Indivior: Jefferies reiterates hold with a target price of 70p.
Read moreUK BROKER RATINGS SUMMARY: Goldman Sachs Upgrades WPP To Buy
Read moreIndivior Chair Howard Pien Takes Medical Leave Of Absence
Read moreIndivior Considers Appeal Options For Suboxone Patent Ruling
Read moreIndivior Posts Quarterly Loss As Suboxone Competitor Hits Market Share
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreIndivior Non-Exec Director Tatjana May To Step Down For New Career
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read morePositive Long-Term Safety Data From Indivior Sublocade Injection Study
Read moreIndivior Withdraws Guidance As Covid-19 Hurts Drug Enrolment
Read more(Sharecast News) - Indivior said remote working was damaging sales as the drugs company withdrew its financial guidance during the Covid-19 crisis.
Read moreIndivior Encouraged By Results From Opioid Addiction Treatment Trial
Read more